Clinical trials
Phase 2 Testicular Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2013 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Terminated | 6 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 8 |
| Fred Hutchinson Cancer Center | 6 |
| National Cancer Institute (NCI) | 4 |
| Children's Oncology Group | 2 |
| City of Hope Medical Center | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| University of Southern California | 2 |
| Wake Forest University Health Sciences | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Cancer Treatment Centers of America | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Testicular Neoplasms | 41 |
| Ovarian Neoplasms | 19 |
| Teratoma | 15 |
| Breast Neoplasms | 12 |
| Burkitt Lymphoma | 12 |
| Neuroblastoma | 12 |
| Carcinoma, Embryonal | 11 |
| Carcinoma, Ovarian Epithelial | 11 |
| Hodgkin Disease | 11 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 11 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.